Reduced nitrate level in individuals with hypertension and diabetes
- PMID: 22022145
- PMCID: PMC3195196
- DOI: 10.4103/0975-3583.85264
Reduced nitrate level in individuals with hypertension and diabetes
Abstract
Background: Nitric oxide (NO) turnover is vital for proper endothelial function to maintain a healthy vascular system. Various risk factors responsible for hypertension and diabetes may disrupt this homeostasis, leading to decreased bioavailability and/or bioactivity of NO, which potentiates endothelial dysfunction. Plasma NO is a useful indicator of NO homeostasis and vascular endothelial function. Since endothelial function plays a key role in the development and progression of diseases like diabetes and hypertension, we sought to investigate the NO profile in patients having diabetes and hypertension and determine the relationship of NO turnover with the disease.
Materials and methods: For this purpose, three groups were studied for the NO production. The first group consisted of 74 hypertensive patients, the second group consisted of 72 diabetic patients and the third group consisted of 60 healthy controls. Nitrate synthase activity was evaluated by measuring nitrate level using an automated sample injector connected to an automated NO detector - Ion liquid chromatograph.
Results: The plasma concentration of NO was found to be significantly lower in both essential hypertensive patients and diabetic patients without complications as compared to the healthy controls (P < 0.05).
Conclusion: This data confirms that different factors like hyperglycemia and blood pressure are seen to have immense influence on NO production.
Keywords: Diabetes; hypertension; nitric oxide.
Conflict of interest statement
Similar articles
-
Sildenafil treatment in a nonsevere hypertensive murine model lowers blood pressure without reducing fetal growth.Am J Obstet Gynecol. 2016 Sep;215(3):386.e1-8. doi: 10.1016/j.ajog.2016.05.002. Epub 2016 May 10. Am J Obstet Gynecol. 2016. PMID: 27177526
-
Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.Eur J Pharmacol. 2007 Sep 10;570(1-3):149-58. doi: 10.1016/j.ejphar.2007.05.031. Epub 2007 Jun 5. Eur J Pharmacol. 2007. PMID: 17612521
-
Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.J Physiol Pharmacol. 2015 Feb;66(1):65-72. J Physiol Pharmacol. 2015. PMID: 25716966
-
Therapeutic value of stimulating the nitrate-nitrite-nitric oxide pathway to attenuate oxidative stress and restore nitric oxide bioavailability in cardiorenal disease.J Intern Med. 2019 Jan;285(1):2-18. doi: 10.1111/joim.12818. Epub 2018 Aug 28. J Intern Med. 2019. PMID: 30039620 Review.
-
Endothelial dysfunction in diabetes and hypertension: Role of microRNAs and long non-coding RNAs.Life Sci. 2018 Nov 15;213:258-268. doi: 10.1016/j.lfs.2018.10.028. Epub 2018 Oct 17. Life Sci. 2018. PMID: 30342074 Review.
Cited by
-
Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo.Diabetologia. 2014 Jul;57(7):1485-94. doi: 10.1007/s00125-014-3243-7. Epub 2014 Apr 24. Diabetologia. 2014. PMID: 24759959
-
Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets.Int J Mol Sci. 2022 Apr 29;23(9):4973. doi: 10.3390/ijms23094973. Int J Mol Sci. 2022. PMID: 35563363 Free PMC article. Review.
-
Relationship between guanosine triphosphate pathway and tetrahydrobiopterin in gestational diabetes mellitus.J Diabetes Metab Disord. 2020 Oct 13;19(2):1391-1396. doi: 10.1007/s40200-020-00659-1. eCollection 2020 Dec. J Diabetes Metab Disord. 2020. PMID: 33520842 Free PMC article.
-
Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients.PLoS One. 2015 Apr 20;10(4):e0125270. doi: 10.1371/journal.pone.0125270. eCollection 2015. PLoS One. 2015. PMID: 25894234 Free PMC article.
-
Brain and cardiovascular-related changes are associated with aging, hypertension, and atrial fibrillation.Clin Auton Res. 2022 Dec;32(6):409-422. doi: 10.1007/s10286-022-00907-9. Epub 2022 Nov 21. Clin Auton Res. 2022. PMID: 36409380 Review.
References
-
- Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26. - PubMed
-
- Nathan C, Xie QW. Nitric oxide synthases: Roles, tolls and controls. Cell. 1994;78:95–118. - PubMed
-
- Stuehr DJ. Mammalian nitric oxide synthases.Biochim Biophys. Acta. 1999;1411:217–30. - PubMed
-
- Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med. 1997;48:489–509. - PubMed
LinkOut - more resources
Full Text Sources